Active Ingredient History
Tetrahydrocannabinol (THC) is a terpenoid found in cannabis. It is the principal psychoactive constituent of cannabis and one of at least 113 total cannabinoids identified on the plant. Its chemical formula C21H30O2 includes compounds, the term THC usually refers to the delta-9-THC isomer with chemical name (−)-trans-Δ9-tetrahydrocannabinol. It is a colorless oil. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Pain (Phase 2)
Accidents, Traffic (Phase 4)
Acute Pain (Phase 2)
Affect (Phase 2)
Aging (Phase 1)
Agoraphobia (Phase 3)
Alcohol Drinking (Phase 4)
Alcohol-Induced Disorders (Phase 1)
Alcoholism (Phase 2)
Alzheimer Disease (Phase 1)
Anorexia (Phase 1)
Anxiety (Phase 2/Phase 3)
Anxiety Disorders (Phase 3)
Appetite (Phase 2)
Back Pain (Phase 3)
Biological Availability (Phase 1)
Bipolar Disorder (Phase 1)
Brain Neoplasms (Phase 2)
Breakthrough Pain (Phase 2)
Breast Neoplasms (Early Phase 1)
Cachexia (Phase 3)
Cancer Pain (Phase 3)
Cannabidiol (Phase 2)
Cannabinoids (Phase 2)
Cannabis (Phase 4)
Cerebral Palsy (Phase 3)
Chronic Pain (Phase 4)
Colonic Neoplasms (Early Phase 1)
Dementia (Phase 2)
Depression (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetes Mellitus, Type 2 (Phase 1)
Diabetic Neuropathies (Phase 3)
Dialysis (Phase 1)
Dronabinol (Phase 3)
Drug Interactions (Phase 1)
Drug-Related Side Effects and Adverse Reactions (Early Phase 1)
Drugs, Investigational (Phase 1)
Dysmenorrhea (Phase 2)
Emergency Service, Hospital (Phase 1)
Endometriosis (Phase 2)
Epilepsy (Phase 1)
Essential Tremor (Phase 1/Phase 2)
Fatigue (Phase 2)
Fibromyalgia (Phase 2/Phase 3)
Glioblastoma (Phase 2)
Headache Disorders, Secondary (Phase 4)
Healthy Volunteers (Phase 1)
HIV (Phase 2)
HIV Infections (Phase 2)
Inflammation (Phase 2)
Ketamine (Phase 1)
Kidney Diseases (Phase 1)
Liver Diseases (Phase 1)
Magnetic Resonance Imaging (Phase 1)
Malnutrition (Phase 1)
Marijuana Abuse (Phase 2)
Marijuana Use (Early Phase 1)
Microbiota (Phase 2)
Migraine Disorders (Phase 4)
Mood Disorders (Phase 2)
Morbidity (Phase 2)
Mortality (Phase 2)
Multiple Sclerosis (Phase 4)
Muscle Spasticity (Phase 4)
Nausea (Phase 2)
Neck Pain (Phase 3)
Neoplasms (Phase 3)
Neuralgia (Phase 3)
Neuroinflammatory Diseases (Phase 2)
Neuromyelitis Optica (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pain (Phase 3)
Pain, Postoperative (Phase 2/Phase 3)
Pain Threshold (Phase 2)
Palliative Care (Phase 3)
Palliative Medicine (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pancreatitis, Chronic (Phase 2)
Panic Disorder (Phase 3)
Peripheral Nervous System Diseases (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacology (Phase 1)
Phobia, Social (Phase 3)
Postoperative Nausea and Vomiting (Phase 2/Phase 3)
Psychomotor Agitation (Early Phase 1)
Psychomotor Disorders (Early Phase 1)
Quality of Life (Phase 2)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 1)
Schizophrenia (Phase 1)
Skin Absorption (Phase 1)
Sleep (Phase 2)
Sleep Apnea, Obstructive (Phase 1)
Sleep Wake Disorders (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stress Disorders, Post-Traumatic (Phase 4)
Substance Abuse, Oral (Phase 1)
Substance-Related Disorders (Phase 1)
Tic Disorders (Phase 3)
Tourette Syndrome (Phase 3)
Urinary Bladder (Phase 3)
Vaping (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue